HHealthcare Read More Pfizer Lyme disease vaccine fails trial, company to seek FDA approvalMarch 23, 2026 Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…
MMedication Read More FDA approves high dose version of Novo Nordisk’s obesity drug WegovyMarch 22, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
HHealthcare Read More Pfizer execs talk Metsera obesity drugFebruary 6, 2026 Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in…
MMedication Read More Trump Touts Drug Cost Savings in TrumpRx Website LaunchFebruary 6, 2026 President Donald Trump launched a new website to help Americans directly buy select medicines at a discount, seeking…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…
HHealthcare Read More Next steps for Eli Lilly, Novo Nordisk, PfizerJanuary 23, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George…
AArtificial intelligence Read More How Pfizer’s AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment StoryJanuary 9, 2026 In early January 2026, Pfizer Inc. and Boltz, PBC announced a collaboration to apply biomolecular AI foundation models…
HHealthcare Read More What You Need to KnowJanuary 6, 2026 Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
HHealthcare Read More FDA Pulls Warning Labels From Hormone Replacement TherapiesNovember 11, 2025 Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about some potential…